Printer Friendly
The Free Library
19,604,530 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

BIO Commemorates the 25th Anniversary of the Orphan Drug Act.


WASHINGTON -- Biotechnology Industry Organization Biotechnology Industry Organization or BIO was founded 1993 in Washington, DC. James C. Greenwood is BIO's current President. External links
  • BIO Website
 (BIO) President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  Jim Greenwood issued the following statement today commemorating the 25th anniversary of the Orphan Drug orphan drug, drug developed under the U.S. Orphan Drug Act (1983) to treat a disease that affects fewer than 200,000 people in the United States. The orphan drug law offers tax breaks and a seven-year monopoly on drug sales to induce companies to undertake the  Act. This landmark law helped lead to the development of new drugs and biologics for rare and frequently untreated diseases by granting seven years of market exclusivity to the developer of a new therapy for a disease which affects less than 200,000 people in the U.S.

"Today we celebrate the 25th anniversary of the Orphan Drug Act. The law has led to a vast increase in the number of therapies available to the more than 25 million Americans living with one of the 7,000 recognized rare diseases and significantly contributed to the growth of the biotechnology industry.

"The biotech industry has historically taken financial risks to develop therapies and cures to serve small patient populations suffering from rare, devastating dev·as·tate  
tr.v. dev·as·tat·ed, dev·as·tat·ing, dev·as·tates
1. To lay waste; destroy.

2. To overwhelm; confound; stun: was devastated by the rude remark.
 diseases. The Orphan Drug Act established some necessary protection to attract the investment required to research and develop these breakthrough technologies."

"In the ten years before the Orphan Drug Act was signed into law, only ten new drugs were developed for rare diseases. In the past 25 years, the Years, The

the seven decades of Eleanor Pargiter’s life. [Br. Lit.: Benét, 1109]

See : Time
 Food & Drug Administration has approved more than 300 drugs to treat orphan diseases.

"BIO also recognizes the anniversary of the establishment of the National Organization for Rare Disorders (NORD Nord (nôr), department (1990 pop. 2,533,000), N France, bordering on the North Sea and Belgium. Lille is the capital. ) which serves patients with rare diseases."

Further information on NORD is available at www.rarediseases.org.

About BIO

BIO represents more than 1,100 biotechnology companies Top 100 Biotechnology Companies
The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies.
, academic institutions, state biotechnology centers and related organizations across the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area.  and 31 other nations. BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the annual BIO International Convention, the global event for biotechnology. www.bio.org
Upcoming BIO Events

-- BIO-Asia Partnering Conference
January 28-29, 2008
Tokyo, Japan

-- BIO CEO & Investor Conference
February 11-13, 2008
New York, NY

-- Partnering for Global Health
March 10-12, 2008
Washington, DC

-- BIO-Europe Spring
April 7-9, 2008
Madrid, Spain

-- World Congress on Industrial Biotechnology & Bioprocessing
April 27-30, 2008
Chicago, IL

-- BIO International Convention
June 17-20
San Diego, CA
COPYRIGHT 2008 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008, Gale Group. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jan 4, 2008
Words:354
Previous Article:Goldberg Kohn Names Three New Principals.
Next Article:Culinary Institute of Virginia Announces Open House.
Topics:



Related Articles
Orphan Drug Act on congressional agenda.
The Irony of Nutritional Supplements.
Development of orphan vaccines: an industry perspective.
CIR CELEBRATES ITS 25TH YEAR ANNIVERSARY.
We All Want to Change the World.
The legacy of a housewife from Connecticut.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles